XML 21 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
1 Months Ended 12 Months Ended 10 Months Ended 12 Months Ended
Dec. 31, 2010
Dec. 31, 2011
Nov. 15, 2010
PREDECESSOR
Dec. 31, 2009
PREDECESSOR
Operating activities:        
Net income (loss)-including noncontrolling interest $ 6,183 $ 52,992 $ (176,349) $ (10,292)
Adjustments to reconcile net income (loss) to cash provided by operating activities:        
Depreciation and amortization 2,315 20,992 22,448 26,161
Impairment charges     263,155 71,991
Amortization of discount and deferred debt issuance costs 70 2,943 1,577 1,221
Share-based compensation   2,383 6,201 4,259
Deferred income taxes, net (6,557) 4,450 (55,598) (9,762)
Provision for losses on accounts receivable 844 5,851 9,573 9,009
Excess tax expense (benefit) from share-based compensation     1,176 369
Gain on purchase of businesses       (1,474)
Write down of assets held for sale   1,642    
Loss (gain) on sale of assets (27) 481 198 269
Changes in operating assets and liabilities:        
Accounts receivable 49,723 (10,125) (64,732) 11,176
Prepaid expenses and other current assets (2,246) 342 (1,692) 792
Other assets 2,723 (3,657) 1,439 (1,627)
Accounts payable 9,282 (9,711) 3,150 (4,893)
Accrued expenses (9,082) (3,846) 4,469 3,840
Deferred gains   300 (3,172) (794)
Accrued income taxes 1,559 (10,668) 5,873 (1,838)
Long-term liabilities and other 4,687 18,243 8,110 6,230
Cash provided by operating activities 59,474 72,612 25,826 104,637
Investing activities:        
Purchases of property and equipment (2,127) (13,507) (8,593) (15,928)
Acquisitions of businesses, net of cash acquired (7,192) (23,106) (21,234) (20,397)
Proceeds from sale of assets 59 221 120 188
Cash used in investing activities (9,260) (36,392) (29,707) (36,137)
Financing activities:        
Long-term debt repayments (122,388) (38,824) (1,395) (811)
Long-term debt borrowings 366,600   2,594  
Short-term (repayments) borrowings-three months or less, net (50,000)   6,000 (59,800)
Payments on obligations under capital leases (11) (92) (85) (121)
Debt issuance costs (15,863) (561) (4,543) (72)
Payments for common share exchange (56,875)      
Redemption of preferred shares (158,843)      
Return on preferred shares (753)      
Funds contributed by co-investors   1,400    
Proceeds received from exercise of stock options       415
Excess tax expense from share-based compensation     (1,176) (369)
Employee withholding payments on share-based compensation     (2,683) (1,379)
Cash used in financing activities (38,133) (38,077) (1,288) (62,137)
Effect of exchange rate changes on cash and cash equivalents 12 (44) (44) 715
Increase (decrease) in cash and cash equivalents 12,093 (1,901) (5,213) 7,078
Cash and cash equivalents at beginning of period 15,459 27,552 20,672 13,594
Cash and cash equivalents at end of period 27,552 25,651 15,459 20,672
Cash paid for:        
Interest 2,743 30,737 16,001 15,093
Income taxes (net of refunds of $0.3 million, $0.1 million, $1.2 million and $0.3 million, respectively) 1,210 5,864 1,160 9,889
Supplemental schedule of non-cash investing and financing activities:        
Notes issued in connection with acquisitions   2,138 4,137 1,764
New capital lease obligations     (725) 733
Forgiveness of management fees and promissory notes in connection with acquisitions   $ 2,706